Clinical Trial: A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)

U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06797674) titled 'A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)' on Jan. 21.

Brief Summary: The goal of the study is to learn what happens to levels of MK-7602 in a healthy person's body over time. Researchers will compare what happens to MK-7602 in the body when it is given with or without another medicine called efavirenz.

Study Start Date: Feb. 10

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: MK-7602

Capsule

DRUG: Efavirenz

Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Curated by HT Syndication....